More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.
A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's Hospital.
Seattle Genetics and Takeda's cancer drug subsidiary have started a late-stage clinical trial for a lymphoma drug, the companies said Wednesday.
Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.
The Food and Drug Administration has approved a new biotech drug for treating two types of lymphoma, the agency said Friday.
NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...
Stater Bros. is partnering with The Leukemia & Lymphoma Society for three weeks in June...
In the first study of vitamin K and non-Hodgkin's lymphoma risk, researchers at the Mayo...
A Food and Drug Administration advisory committee declined to recommend approval for a cancer drug...